カテゴリー： LP Information, 世界, 医療/バイオ

世界の腫瘍マーカー迅速検査市場予測 2023年-2029年

◆英語タイトル：Global Rapid Tumor Marker Tests Market Growth 2023-2029

LP Informationが発行した調査報告書（LP23JU4110）◆商品コード：LP23JU4110
◆発行会社（リサーチ会社）：LP Information
◆発行日：2023年5月
◆ページ数：106
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野：医療装置＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥556,320見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥834,480見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,112,640見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の腫瘍マーカー迅速検査市場」は、過去の販売実績から2022年の世界の腫瘍マーカー迅速検査の総販売量を検討し、2023年から2029年の予測される腫瘍マーカー迅速検査の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の腫瘍マーカー迅速検査の市場規模を掲載し、XXX百万米ドル規模の世界の腫瘍マーカー迅速検査市場の詳細な分析を提供します。本インサイトレポートは、世界の腫瘍マーカー迅速検査業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。
また、本レポートでは、加速する世界の腫瘍マーカー迅速検査市場における各社の独自のポジションをより深く理解するために、腫瘍マーカー迅速検査製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の腫瘍マーカー迅速検査市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。腫瘍マーカー迅速検査の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。腫瘍マーカー迅速検査の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。腫瘍マーカー迅速検査のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

腫瘍マーカー迅速検査の世界主要メーカーとしては、Biomerieux、 Labcorp、 JOYSBIO、 Fujirebio、 GRAIL、 Randox、 Wondfo Biotech、 Orient Gene、 Hangzhou Biotest、 Assure Tech、 Aotai Bio、 Wantai BioPharm、 Bioneovanなどを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の腫瘍マーカー迅速検査市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では腫瘍マーカー迅速検査市場をセグメンテーションし、種類別 (血液検査、尿検査、体組織検査、その他)、用途別 (肺がん、乳がん、胃がん、肝臓がん、食道がん、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：血液検査、尿検査、体組織検査、その他

・用途別区分：肺がん、乳がん、胃がん、肝臓がん、食道がん、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の腫瘍マーカー迅速検査市場の10年間の市場状況・展望は？
・世界および地域別に見た腫瘍マーカー迅速検査市場成長の要因は何か？
・腫瘍マーカー迅速検査の市場機会はエンドマーケットの規模によってどのように変化するのか？
・腫瘍マーカー迅速検査のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：腫瘍マーカー迅速検査の年間販売量2018-2029、地域別現状・将来分析
・腫瘍マーカー迅速検査の種類別セグメント：血液検査、尿検査、体組織検査、その他
・腫瘍マーカー迅速検査の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・腫瘍マーカー迅速検査の用途別セグメント：肺がん、乳がん、胃がん、肝臓がん、食道がん、その他
・腫瘍マーカー迅速検査の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の腫瘍マーカー迅速検査市場
・企業別のグローバル腫瘍マーカー迅速検査市場データ：2018-2023年の年間販売量、市場シェア
・企業別の腫瘍マーカー迅速検査の年間売上：2018-2023年の売上、市場シェア
・企業別の腫瘍マーカー迅速検査販売価格
・主要企業の腫瘍マーカー迅速検査生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

腫瘍マーカー迅速検査の地域別レビュー
・地域別の腫瘍マーカー迅速検査市場規模2018-2023：年間販売量、売上
・主要国別の腫瘍マーカー迅速検査市場規模2018-2023：年間販売量、売上
・南北アメリカの腫瘍マーカー迅速検査販売の成長
・アジア太平洋の腫瘍マーカー迅速検査販売の成長
・ヨーロッパの腫瘍マーカー迅速検査販売の成長
・中東・アフリカの腫瘍マーカー迅速検査販売の成長

南北アメリカ市場
・南北アメリカの国別の腫瘍マーカー迅速検査販売量、売上（2018-2023）
・南北アメリカの腫瘍マーカー迅速検査の種類別販売量
・南北アメリカの腫瘍マーカー迅速検査の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の腫瘍マーカー迅速検査販売量、売上（2018-2023）
・アジア太平洋の腫瘍マーカー迅速検査の種類別販売量
・アジア太平洋の腫瘍マーカー迅速検査の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の腫瘍マーカー迅速検査販売量、売上（2018-2023）
・ヨーロッパの腫瘍マーカー迅速検査の種類別販売量
・ヨーロッパの腫瘍マーカー迅速検査の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の腫瘍マーカー迅速検査販売量、売上（2018-2023）
・中東・アフリカの腫瘍マーカー迅速検査の種類別販売量
・中東・アフリカの腫瘍マーカー迅速検査の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・腫瘍マーカー迅速検査の製造コスト構造分析
・腫瘍マーカー迅速検査の製造プロセス分析
・腫瘍マーカー迅速検査の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・腫瘍マーカー迅速検査の主要なグローバル販売業者
・腫瘍マーカー迅速検査の主要なグローバル顧客

地域別の腫瘍マーカー迅速検査市場予測レビュー
・地域別の腫瘍マーカー迅速検査市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・腫瘍マーカー迅速検査の種類別市場規模予測
・腫瘍マーカー迅速検査の用途別市場規模予測

主要企業分析
Biomerieux、 Labcorp、 JOYSBIO、 Fujirebio、 GRAIL、 Randox、 Wondfo Biotech、 Orient Gene、 Hangzhou Biotest、 Assure Tech、 Aotai Bio、 Wantai BioPharm、 Bioneovan
・企業情報
・腫瘍マーカー迅速検査製品
・腫瘍マーカー迅速検査販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

Tumor Marker Test Kits in this report.
LPI (LP Information)’ newest research report, the “Rapid Tumor Marker Tests Industry Forecast” looks at past sales and reviews total world Rapid Tumor Marker Tests sales in 2022, providing a comprehensive analysis by region and market sector of projected Rapid Tumor Marker Tests sales for 2023 through 2029. With Rapid Tumor Marker Tests sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Rapid Tumor Marker Tests industry.
This Insight Report provides a comprehensive analysis of the global Rapid Tumor Marker Tests landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Rapid Tumor Marker Tests portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Rapid Tumor Marker Tests market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Rapid Tumor Marker Tests and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Rapid Tumor Marker Tests.
The global Rapid Tumor Marker Tests market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Rapid Tumor Marker Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Rapid Tumor Marker Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Rapid Tumor Marker Tests is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Rapid Tumor Marker Tests players cover Biomerieux, Labcorp, JOYSBIO, Fujirebio, GRAIL, Randox, Wondfo Biotech, Orient Gene and Hangzhou Biotest, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid Tumor Marker Tests market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Blood Testing
Urine Testing
Body Tissue Testing
Others
Segmentation by application
Lung Cancer
Breast Cancer
Stomach Cancer
Liver Cancer
Esophageal Cancer
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Biomerieux
Labcorp
JOYSBIO
Fujirebio
GRAIL
Randox
Wondfo Biotech
Orient Gene
Hangzhou Biotest
Assure Tech
Aotai Bio
Wantai BioPharm
Bioneovan
Key Questions Addressed in this Report
What is the 10-year outlook for the global Rapid Tumor Marker Tests market?
What factors are driving Rapid Tumor Marker Tests market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Rapid Tumor Marker Tests market opportunities vary by end market size?
How does Rapid Tumor Marker Tests break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Rapid Tumor Marker Tests Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Rapid Tumor Marker Tests by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Rapid Tumor Marker Tests by Country/Region, 2018, 2022 & 2029
2.2 Rapid Tumor Marker Tests Segment by Type
2.2.1 Blood Testing
2.2.2 Urine Testing
2.2.3 Body Tissue Testing
2.2.4 Others
2.3 Rapid Tumor Marker Tests Sales by Type
2.3.1 Global Rapid Tumor Marker Tests Sales Market Share by Type (2018-2023)
2.3.2 Global Rapid Tumor Marker Tests Revenue and Market Share by Type (2018-2023)
2.3.3 Global Rapid Tumor Marker Tests Sale Price by Type (2018-2023)
2.4 Rapid Tumor Marker Tests Segment by Application
2.4.1 Lung Cancer
2.4.2 Breast Cancer
2.4.3 Stomach Cancer
2.4.4 Liver Cancer
2.4.5 Esophageal Cancer
2.4.6 Others
2.5 Rapid Tumor Marker Tests Sales by Application
2.5.1 Global Rapid Tumor Marker Tests Sale Market Share by Application (2018-2023)
2.5.2 Global Rapid Tumor Marker Tests Revenue and Market Share by Application (2018-2023)
2.5.3 Global Rapid Tumor Marker Tests Sale Price by Application (2018-2023)
3 Global Rapid Tumor Marker Tests by Company
3.1 Global Rapid Tumor Marker Tests Breakdown Data by Company
3.1.1 Global Rapid Tumor Marker Tests Annual Sales by Company (2018-2023)
3.1.2 Global Rapid Tumor Marker Tests Sales Market Share by Company (2018-2023)
3.2 Global Rapid Tumor Marker Tests Annual Revenue by Company (2018-2023)
3.2.1 Global Rapid Tumor Marker Tests Revenue by Company (2018-2023)
3.2.2 Global Rapid Tumor Marker Tests Revenue Market Share by Company (2018-2023)
3.3 Global Rapid Tumor Marker Tests Sale Price by Company
3.4 Key Manufacturers Rapid Tumor Marker Tests Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Rapid Tumor Marker Tests Product Location Distribution
3.4.2 Players Rapid Tumor Marker Tests Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Rapid Tumor Marker Tests by Geographic Region
4.1 World Historic Rapid Tumor Marker Tests Market Size by Geographic Region (2018-2023)
4.1.1 Global Rapid Tumor Marker Tests Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Rapid Tumor Marker Tests Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Rapid Tumor Marker Tests Market Size by Country/Region (2018-2023)
4.2.1 Global Rapid Tumor Marker Tests Annual Sales by Country/Region (2018-2023)
4.2.2 Global Rapid Tumor Marker Tests Annual Revenue by Country/Region (2018-2023)
4.3 Americas Rapid Tumor Marker Tests Sales Growth
4.4 APAC Rapid Tumor Marker Tests Sales Growth
4.5 Europe Rapid Tumor Marker Tests Sales Growth
4.6 Middle East & Africa Rapid Tumor Marker Tests Sales Growth
5 Americas
5.1 Americas Rapid Tumor Marker Tests Sales by Country
5.1.1 Americas Rapid Tumor Marker Tests Sales by Country (2018-2023)
5.1.2 Americas Rapid Tumor Marker Tests Revenue by Country (2018-2023)
5.2 Americas Rapid Tumor Marker Tests Sales by Type
5.3 Americas Rapid Tumor Marker Tests Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Rapid Tumor Marker Tests Sales by Region
6.1.1 APAC Rapid Tumor Marker Tests Sales by Region (2018-2023)
6.1.2 APAC Rapid Tumor Marker Tests Revenue by Region (2018-2023)
6.2 APAC Rapid Tumor Marker Tests Sales by Type
6.3 APAC Rapid Tumor Marker Tests Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Rapid Tumor Marker Tests by Country
7.1.1 Europe Rapid Tumor Marker Tests Sales by Country (2018-2023)
7.1.2 Europe Rapid Tumor Marker Tests Revenue by Country (2018-2023)
7.2 Europe Rapid Tumor Marker Tests Sales by Type
7.3 Europe Rapid Tumor Marker Tests Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Rapid Tumor Marker Tests by Country
8.1.1 Middle East & Africa Rapid Tumor Marker Tests Sales by Country (2018-2023)
8.1.2 Middle East & Africa Rapid Tumor Marker Tests Revenue by Country (2018-2023)
8.2 Middle East & Africa Rapid Tumor Marker Tests Sales by Type
8.3 Middle East & Africa Rapid Tumor Marker Tests Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Rapid Tumor Marker Tests
10.3 Manufacturing Process Analysis of Rapid Tumor Marker Tests
10.4 Industry Chain Structure of Rapid Tumor Marker Tests
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Rapid Tumor Marker Tests Distributors
11.3 Rapid Tumor Marker Tests Customer
12 World Forecast Review for Rapid Tumor Marker Tests by Geographic Region
12.1 Global Rapid Tumor Marker Tests Market Size Forecast by Region
12.1.1 Global Rapid Tumor Marker Tests Forecast by Region (2024-2029)
12.1.2 Global Rapid Tumor Marker Tests Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Rapid Tumor Marker Tests Forecast by Type
12.7 Global Rapid Tumor Marker Tests Forecast by Application
13 Key Players Analysis
13.1 Biomerieux
13.1.1 Biomerieux Company Information
13.1.2 Biomerieux Rapid Tumor Marker Tests Product Portfolios and Specifications
13.1.3 Biomerieux Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Biomerieux Main Business Overview
13.1.5 Biomerieux Latest Developments
13.2 Labcorp
13.2.1 Labcorp Company Information
13.2.2 Labcorp Rapid Tumor Marker Tests Product Portfolios and Specifications
13.2.3 Labcorp Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Labcorp Main Business Overview
13.2.5 Labcorp Latest Developments
13.3 JOYSBIO
13.3.1 JOYSBIO Company Information
13.3.2 JOYSBIO Rapid Tumor Marker Tests Product Portfolios and Specifications
13.3.3 JOYSBIO Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 JOYSBIO Main Business Overview
13.3.5 JOYSBIO Latest Developments
13.4 Fujirebio
13.4.1 Fujirebio Company Information
13.4.2 Fujirebio Rapid Tumor Marker Tests Product Portfolios and Specifications
13.4.3 Fujirebio Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Fujirebio Main Business Overview
13.4.5 Fujirebio Latest Developments
13.5 GRAIL
13.5.1 GRAIL Company Information
13.5.2 GRAIL Rapid Tumor Marker Tests Product Portfolios and Specifications
13.5.3 GRAIL Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GRAIL Main Business Overview
13.5.5 GRAIL Latest Developments
13.6 Randox
13.6.1 Randox Company Information
13.6.2 Randox Rapid Tumor Marker Tests Product Portfolios and Specifications
13.6.3 Randox Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Randox Main Business Overview
13.6.5 Randox Latest Developments
13.7 Wondfo Biotech
13.7.1 Wondfo Biotech Company Information
13.7.2 Wondfo Biotech Rapid Tumor Marker Tests Product Portfolios and Specifications
13.7.3 Wondfo Biotech Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Wondfo Biotech Main Business Overview
13.7.5 Wondfo Biotech Latest Developments
13.8 Orient Gene
13.8.1 Orient Gene Company Information
13.8.2 Orient Gene Rapid Tumor Marker Tests Product Portfolios and Specifications
13.8.3 Orient Gene Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Orient Gene Main Business Overview
13.8.5 Orient Gene Latest Developments
13.9 Hangzhou Biotest
13.9.1 Hangzhou Biotest Company Information
13.9.2 Hangzhou Biotest Rapid Tumor Marker Tests Product Portfolios and Specifications
13.9.3 Hangzhou Biotest Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Hangzhou Biotest Main Business Overview
13.9.5 Hangzhou Biotest Latest Developments
13.10 Assure Tech
13.10.1 Assure Tech Company Information
13.10.2 Assure Tech Rapid Tumor Marker Tests Product Portfolios and Specifications
13.10.3 Assure Tech Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Assure Tech Main Business Overview
13.10.5 Assure Tech Latest Developments
13.11 Aotai Bio
13.11.1 Aotai Bio Company Information
13.11.2 Aotai Bio Rapid Tumor Marker Tests Product Portfolios and Specifications
13.11.3 Aotai Bio Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Aotai Bio Main Business Overview
13.11.5 Aotai Bio Latest Developments
13.12 Wantai BioPharm
13.12.1 Wantai BioPharm Company Information
13.12.2 Wantai BioPharm Rapid Tumor Marker Tests Product Portfolios and Specifications
13.12.3 Wantai BioPharm Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Wantai BioPharm Main Business Overview
13.12.5 Wantai BioPharm Latest Developments
13.13 Bioneovan
13.13.1 Bioneovan Company Information
13.13.2 Bioneovan Rapid Tumor Marker Tests Product Portfolios and Specifications
13.13.3 Bioneovan Rapid Tumor Marker Tests Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Bioneovan Main Business Overview
13.13.5 Bioneovan Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Rapid Tumor Marker Tests Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Rapid Tumor Marker Tests Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Blood Testing
Table 4. Major Players of Urine Testing
Table 5. Major Players of Body Tissue Testing
Table 6. Major Players of Others
Table 7. Global Rapid Tumor Marker Tests Sales by Type (2018-2023) & (K Units)
Table 8. Global Rapid Tumor Marker Tests Sales Market Share by Type (2018-2023)
Table 9. Global Rapid Tumor Marker Tests Revenue by Type (2018-2023) & ($ million)
Table 10. Global Rapid Tumor Marker Tests Revenue Market Share by Type (2018-2023)
Table 11. Global Rapid Tumor Marker Tests Sale Price by Type (2018-2023) & (USD/Unit)
Table 12. Global Rapid Tumor Marker Tests Sales by Application (2018-2023) & (K Units)
Table 13. Global Rapid Tumor Marker Tests Sales Market Share by Application (2018-2023)
Table 14. Global Rapid Tumor Marker Tests Revenue by Application (2018-2023)
Table 15. Global Rapid Tumor Marker Tests Revenue Market Share by Application (2018-2023)
Table 16. Global Rapid Tumor Marker Tests Sale Price by Application (2018-2023) & (USD/Unit)
Table 17. Global Rapid Tumor Marker Tests Sales by Company (2018-2023) & (K Units)
Table 18. Global Rapid Tumor Marker Tests Sales Market Share by Company (2018-2023)
Table 19. Global Rapid Tumor Marker Tests Revenue by Company (2018-2023) ($ Millions)
Table 20. Global Rapid Tumor Marker Tests Revenue Market Share by Company (2018-2023)
Table 21. Global Rapid Tumor Marker Tests Sale Price by Company (2018-2023) & (USD/Unit)
Table 22. Key Manufacturers Rapid Tumor Marker Tests Producing Area Distribution and Sales Area
Table 23. Players Rapid Tumor Marker Tests Products Offered
Table 24. Rapid Tumor Marker Tests Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Rapid Tumor Marker Tests Sales by Geographic Region (2018-2023) & (K Units)
Table 28. Global Rapid Tumor Marker Tests Sales Market Share Geographic Region (2018-2023)
Table 29. Global Rapid Tumor Marker Tests Revenue by Geographic Region (2018-2023) & ($ millions)
Table 30. Global Rapid Tumor Marker Tests Revenue Market Share by Geographic Region (2018-2023)
Table 31. Global Rapid Tumor Marker Tests Sales by Country/Region (2018-2023) & (K Units)
Table 32. Global Rapid Tumor Marker Tests Sales Market Share by Country/Region (2018-2023)
Table 33. Global Rapid Tumor Marker Tests Revenue by Country/Region (2018-2023) & ($ millions)
Table 34. Global Rapid Tumor Marker Tests Revenue Market Share by Country/Region (2018-2023)
Table 35. Americas Rapid Tumor Marker Tests Sales by Country (2018-2023) & (K Units)
Table 36. Americas Rapid Tumor Marker Tests Sales Market Share by Country (2018-2023)
Table 37. Americas Rapid Tumor Marker Tests Revenue by Country (2018-2023) & ($ Millions)
Table 38. Americas Rapid Tumor Marker Tests Revenue Market Share by Country (2018-2023)
Table 39. Americas Rapid Tumor Marker Tests Sales by Type (2018-2023) & (K Units)
Table 40. Americas Rapid Tumor Marker Tests Sales by Application (2018-2023) & (K Units)
Table 41. APAC Rapid Tumor Marker Tests Sales by Region (2018-2023) & (K Units)
Table 42. APAC Rapid Tumor Marker Tests Sales Market Share by Region (2018-2023)
Table 43. APAC Rapid Tumor Marker Tests Revenue by Region (2018-2023) & ($ Millions)
Table 44. APAC Rapid Tumor Marker Tests Revenue Market Share by Region (2018-2023)
Table 45. APAC Rapid Tumor Marker Tests Sales by Type (2018-2023) & (K Units)
Table 46. APAC Rapid Tumor Marker Tests Sales by Application (2018-2023) & (K Units)
Table 47. Europe Rapid Tumor Marker Tests Sales by Country (2018-2023) & (K Units)
Table 48. Europe Rapid Tumor Marker Tests Sales Market Share by Country (2018-2023)
Table 49. Europe Rapid Tumor Marker Tests Revenue by Country (2018-2023) & ($ Millions)
Table 50. Europe Rapid Tumor Marker Tests Revenue Market Share by Country (2018-2023)
Table 51. Europe Rapid Tumor Marker Tests Sales by Type (2018-2023) & (K Units)
Table 52. Europe Rapid Tumor Marker Tests Sales by Application (2018-2023) & (K Units)
Table 53. Middle East & Africa Rapid Tumor Marker Tests Sales by Country (2018-2023) & (K Units)
Table 54. Middle East & Africa Rapid Tumor Marker Tests Sales Market Share by Country (2018-2023)
Table 55. Middle East & Africa Rapid Tumor Marker Tests Revenue by Country (2018-2023) & ($ Millions)
Table 56. Middle East & Africa Rapid Tumor Marker Tests Revenue Market Share by Country (2018-2023)
Table 57. Middle East & Africa Rapid Tumor Marker Tests Sales by Type (2018-2023) & (K Units)
Table 58. Middle East & Africa Rapid Tumor Marker Tests Sales by Application (2018-2023) & (K Units)
Table 59. Key Market Drivers & Growth Opportunities of Rapid Tumor Marker Tests
Table 60. Key Market Challenges & Risks of Rapid Tumor Marker Tests
Table 61. Key Industry Trends of Rapid Tumor Marker Tests
Table 62. Rapid Tumor Marker Tests Raw Material
Table 63. Key Suppliers of Raw Materials
Table 64. Rapid Tumor Marker Tests Distributors List
Table 65. Rapid Tumor Marker Tests Customer List
Table 66. Global Rapid Tumor Marker Tests Sales Forecast by Region (2024-2029) & (K Units)
Table 67. Global Rapid Tumor Marker Tests Revenue Forecast by Region (2024-2029) & ($ millions)
Table 68. Americas Rapid Tumor Marker Tests Sales Forecast by Country (2024-2029) & (K Units)
Table 69. Americas Rapid Tumor Marker Tests Revenue Forecast by Country (2024-2029) & ($ millions)
Table 70. APAC Rapid Tumor Marker Tests Sales Forecast by Region (2024-2029) & (K Units)
Table 71. APAC Rapid Tumor Marker Tests Revenue Forecast by Region (2024-2029) & ($ millions)
Table 72. Europe Rapid Tumor Marker Tests Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Europe Rapid Tumor Marker Tests Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Middle East & Africa Rapid Tumor Marker Tests Sales Forecast by Country (2024-2029) & (K Units)
Table 75. Middle East & Africa Rapid Tumor Marker Tests Revenue Forecast by Country (2024-2029) & ($ millions)
Table 76. Global Rapid Tumor Marker Tests Sales Forecast by Type (2024-2029) & (K Units)
Table 77. Global Rapid Tumor Marker Tests Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 78. Global Rapid Tumor Marker Tests Sales Forecast by Application (2024-2029) & (K Units)
Table 79. Global Rapid Tumor Marker Tests Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 80. Biomerieux Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 81. Biomerieux Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 82. Biomerieux Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Biomerieux Main Business
Table 84. Biomerieux Latest Developments
Table 85. Labcorp Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 86. Labcorp Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 87. Labcorp Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Labcorp Main Business
Table 89. Labcorp Latest Developments
Table 90. JOYSBIO Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 91. JOYSBIO Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 92. JOYSBIO Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. JOYSBIO Main Business
Table 94. JOYSBIO Latest Developments
Table 95. Fujirebio Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 96. Fujirebio Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 97. Fujirebio Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Fujirebio Main Business
Table 99. Fujirebio Latest Developments
Table 100. GRAIL Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 101. GRAIL Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 102. GRAIL Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. GRAIL Main Business
Table 104. GRAIL Latest Developments
Table 105. Randox Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 106. Randox Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 107. Randox Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Randox Main Business
Table 109. Randox Latest Developments
Table 110. Wondfo Biotech Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 111. Wondfo Biotech Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 112. Wondfo Biotech Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Wondfo Biotech Main Business
Table 114. Wondfo Biotech Latest Developments
Table 115. Orient Gene Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 116. Orient Gene Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 117. Orient Gene Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Orient Gene Main Business
Table 119. Orient Gene Latest Developments
Table 120. Hangzhou Biotest Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 121. Hangzhou Biotest Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 122. Hangzhou Biotest Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Hangzhou Biotest Main Business
Table 124. Hangzhou Biotest Latest Developments
Table 125. Assure Tech Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 126. Assure Tech Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 127. Assure Tech Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. Assure Tech Main Business
Table 129. Assure Tech Latest Developments
Table 130. Aotai Bio Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 131. Aotai Bio Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 132. Aotai Bio Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Aotai Bio Main Business
Table 134. Aotai Bio Latest Developments
Table 135. Wantai BioPharm Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 136. Wantai BioPharm Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 137. Wantai BioPharm Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Wantai BioPharm Main Business
Table 139. Wantai BioPharm Latest Developments
Table 140. Bioneovan Basic Information, Rapid Tumor Marker Tests Manufacturing Base, Sales Area and Its Competitors
Table 141. Bioneovan Rapid Tumor Marker Tests Product Portfolios and Specifications
Table 142. Bioneovan Rapid Tumor Marker Tests Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Bioneovan Main Business
Table 144. Bioneovan Latest Developments
List of Figures
Figure 1. Picture of Rapid Tumor Marker Tests
Figure 2. Rapid Tumor Marker Tests Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Rapid Tumor Marker Tests Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Rapid Tumor Marker Tests Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Rapid Tumor Marker Tests Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Blood Testing
Figure 10. Product Picture of Urine Testing
Figure 11. Product Picture of Body Tissue Testing
Figure 12. Product Picture of Others
Figure 13. Global Rapid Tumor Marker Tests Sales Market Share by Type in 2022
Figure 14. Global Rapid Tumor Marker Tests Revenue Market Share by Type (2018-2023)
Figure 15. Rapid Tumor Marker Tests Consumed in Lung Cancer
Figure 16. Global Rapid Tumor Marker Tests Market: Lung Cancer (2018-2023) & (K Units)
Figure 17. Rapid Tumor Marker Tests Consumed in Breast Cancer
Figure 18. Global Rapid Tumor Marker Tests Market: Breast Cancer (2018-2023) & (K Units)
Figure 19. Rapid Tumor Marker Tests Consumed in Stomach Cancer
Figure 20. Global Rapid Tumor Marker Tests Market: Stomach Cancer (2018-2023) & (K Units)
Figure 21. Rapid Tumor Marker Tests Consumed in Liver Cancer
Figure 22. Global Rapid Tumor Marker Tests Market: Liver Cancer (2018-2023) & (K Units)
Figure 23. Rapid Tumor Marker Tests Consumed in Esophageal Cancer
Figure 24. Global Rapid Tumor Marker Tests Market: Esophageal Cancer (2018-2023) & (K Units)
Figure 25. Rapid Tumor Marker Tests Consumed in Others
Figure 26. Global Rapid Tumor Marker Tests Market: Others (2018-2023) & (K Units)
Figure 27. Global Rapid Tumor Marker Tests Sales Market Share by Application (2022)
Figure 28. Global Rapid Tumor Marker Tests Revenue Market Share by Application in 2022
Figure 29. Rapid Tumor Marker Tests Sales Market by Company in 2022 (K Units)
Figure 30. Global Rapid Tumor Marker Tests Sales Market Share by Company in 2022
Figure 31. Rapid Tumor Marker Tests Revenue Market by Company in 2022 ($ Million)
Figure 32. Global Rapid Tumor Marker Tests Revenue Market Share by Company in 2022
Figure 33. Global Rapid Tumor Marker Tests Sales Market Share by Geographic Region (2018-2023)
Figure 34. Global Rapid Tumor Marker Tests Revenue Market Share by Geographic Region in 2022
Figure 35. Americas Rapid Tumor Marker Tests Sales 2018-2023 (K Units)
Figure 36. Americas Rapid Tumor Marker Tests Revenue 2018-2023 ($ Millions)
Figure 37. APAC Rapid Tumor Marker Tests Sales 2018-2023 (K Units)
Figure 38. APAC Rapid Tumor Marker Tests Revenue 2018-2023 ($ Millions)
Figure 39. Europe Rapid Tumor Marker Tests Sales 2018-2023 (K Units)
Figure 40. Europe Rapid Tumor Marker Tests Revenue 2018-2023 ($ Millions)
Figure 41. Middle East & Africa Rapid Tumor Marker Tests Sales 2018-2023 (K Units)
Figure 42. Middle East & Africa Rapid Tumor Marker Tests Revenue 2018-2023 ($ Millions)
Figure 43. Americas Rapid Tumor Marker Tests Sales Market Share by Country in 2022
Figure 44. Americas Rapid Tumor Marker Tests Revenue Market Share by Country in 2022
Figure 45. Americas Rapid Tumor Marker Tests Sales Market Share by Type (2018-2023)
Figure 46. Americas Rapid Tumor Marker Tests Sales Market Share by Application (2018-2023)
Figure 47. United States Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 48. Canada Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 49. Mexico Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 50. Brazil Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 51. APAC Rapid Tumor Marker Tests Sales Market Share by Region in 2022
Figure 52. APAC Rapid Tumor Marker Tests Revenue Market Share by Regions in 2022
Figure 53. APAC Rapid Tumor Marker Tests Sales Market Share by Type (2018-2023)
Figure 54. APAC Rapid Tumor Marker Tests Sales Market Share by Application (2018-2023)
Figure 55. China Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 56. Japan Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 57. South Korea Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 58. Southeast Asia Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 59. India Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 60. Australia Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 61. China Taiwan Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 62. Europe Rapid Tumor Marker Tests Sales Market Share by Country in 2022
Figure 63. Europe Rapid Tumor Marker Tests Revenue Market Share by Country in 2022
Figure 64. Europe Rapid Tumor Marker Tests Sales Market Share by Type (2018-2023)
Figure 65. Europe Rapid Tumor Marker Tests Sales Market Share by Application (2018-2023)
Figure 66. Germany Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 67. France Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 68. UK Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 69. Italy Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 70. Russia Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 71. Middle East & Africa Rapid Tumor Marker Tests Sales Market Share by Country in 2022
Figure 72. Middle East & Africa Rapid Tumor Marker Tests Revenue Market Share by Country in 2022
Figure 73. Middle East & Africa Rapid Tumor Marker Tests Sales Market Share by Type (2018-2023)
Figure 74. Middle East & Africa Rapid Tumor Marker Tests Sales Market Share by Application (2018-2023)
Figure 75. Egypt Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 76. South Africa Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 77. Israel Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 78. Turkey Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 79. GCC Country Rapid Tumor Marker Tests Revenue Growth 2018-2023 ($ Millions)
Figure 80. Manufacturing Cost Structure Analysis of Rapid Tumor Marker Tests in 2022
Figure 81. Manufacturing Process Analysis of Rapid Tumor Marker Tests
Figure 82. Industry Chain Structure of Rapid Tumor Marker Tests
Figure 83. Channels of Distribution
Figure 84. Global Rapid Tumor Marker Tests Sales Market Forecast by Region (2024-2029)
Figure 85. Global Rapid Tumor Marker Tests Revenue Market Share Forecast by Region (2024-2029)
Figure 86. Global Rapid Tumor Marker Tests Sales Market Share Forecast by Type (2024-2029)
Figure 87. Global Rapid Tumor Marker Tests Revenue Market Share Forecast by Type (2024-2029)
Figure 88. Global Rapid Tumor Marker Tests Sales Market Share Forecast by Application (2024-2029)
Figure 89. Global Rapid Tumor Marker Tests Revenue Market Share Forecast by Application (2024-2029)


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の腫瘍マーカー迅速検査市場予測 2023年-2029年(Global Rapid Tumor Marker Tests Market Growth 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 心臓マーカー迅速検査のグローバル市場予測2023-2029
  • 迅速検査の世界市場2022年～2029年：製品別、技術別、用途別、エンドユーザー別、地域別
  • 世界のエイズ迅速検査市場予測 2023年-2029年
  • 世界のがん迅速検査キット市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆